Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
EUDA	EUDA HEALTH HOLDINGS LTD	$78.03M	-5.50%	12.90%	-8.50%	-10.90%	-1.58	0.23	22.40%	5.20%	5.90%
ONCO	ONCONETIX INC	$5.24M	-350.60%	-143.40%	-685.85%	819.20%	2.16	0.07	66.40%	-3,458.20%	-3,321.76%
ENTX	ENTERA BIO LTD	$132.27M	-95.10%	-82.80%	-50.44%	7,950.30%	0.12	13.07	4.00%	-4,525.10%	-4,518.83%
FBLG	FIBROBIOLOGICS INC	$16.46M	-609.20%	-101.20%	-448.93%	-1,214.30%	15.17	0.93	N/A	N/A	N/A
UPC	UNIVERSE PHARMACEUTICALS INC	$2.66M	2.70%	1.70%	2.27%	5.90%	0.46	2.78	30.40%	5.60%	6.74%
AVDL	AVADEL PHARMACEUTICALS PLC	$1.83B	-3.70%	-1.70%	3.28%	4.70%	1.06	2.79	89.60%	-1.30%	1.93%
APRE	APREA THERAPEUTICS INC	$8.16M	-78.90%	-62.70%	-105.05%	583.10%	0.29	5.34	100.00%	-1,646.80%	-1,766.47%
OGEN	ORAGENICS INC	$876.90k	-954.70%	-311.80%	-7,344.29%	3,865.20%	27.10	1.04	N/A	N/A	N/A
BBLG	BONE BIOLOGICS CORP	$3.82M	-177.20%	-164.30%	-63.98%	-3,346.40%	0.06	17.24	N/A	N/A	N/A
LPTX	LEAP THERAPEUTICS INC	$18.52M	-237.60%	-155.40%	-1,138.48%	485.50%	2.51	1.34	N/A	N/A	N/A
NXTC	NEXTCURE INC	$29.45M	-70.20%	-58.10%	-80.66%	-86.50%	0.20	10.26	N/A	N/A	N/A
ZCMD	ZHONGCHAO INC	$17.34M	-9.00%	-6.70%	-4.34%	-6.80%	0.13	8.15	52.50%	-12.90%	-7.92%
SYBX	SYNLOGIC INC	$19.77M	10.90%	7.50%	11.48%	-29.00%	0.37	3.68	N/A	N/A	N/A
ICCC	IMMUCELL CORP	$56.44M	6.20%	3.90%	4.19%	3.40%	0.56	3.85	37.40%	6.20%	6.27%
NTRB	NUTRIBAND INC	$80.99M	-410.60%	-353.10%	-119.11%	-3,780.30%	0.20	4.79	34.40%	-1,244.40%	-397.54%
PCSA	PROCESSA PHARMACEUTICALS INC	$19.59M	-342.40%	-243.50%	-210.93%	-3,727.00%	0.34	3.45	N/A	N/A	N/A
NSYS	NORTECH SYSTEMS INC	$25.70M	-9.70%	-4.50%	-5.61%	-4.20%	1.24	2.77	11.90%	-2.80%	-2.45%
NSPR	INSPIREMD INC	$92.20M	-131.30%	-97.80%	-170.23%	-192.40%	0.65	2.81	21.10%	-585.60%	-584.80%
ANTX	AN2 THERAPEUTICS INC	$33.61M	-48.00%	-43.10%	-54.30%	-68.40%	0.10	9.67	N/A	N/A	N/A
ALUR	ALLURION TECHNOLOGIES INC	$14.36M	N/A	-57.20%	-125.31%	-25.30%	-1.44	2.02	61.80%	-107.70%	-104.15%
LFWD	LIFEWARD LTD	$9.71M	-137.90%	-90.30%	-181.00%	-408.10%	0.77	2.00	35.60%	-121.80%	-121.63%
ADVM	ADVERUM BIOTECHNOLOGIES INC	$90.23M	-332.80%	-113.50%	-283.66%	-121.10%	-5.76	1.54	100.00%	-18,387.40%	-18,387.40%
ESLA	ESTRELLA IMMUNOPHARMA INC	$89.70M	N/A	-392.70%	198.13%	420.40%	-1.49	0.16	N/A	N/A	N/A
ALZN	ALZAMEND NEURO INC	$7.94M	-166.80%	-137.00%	-116.68%	4,925.40%	0.18	6.03	N/A	N/A	N/A
NLSP	NLS PHARMACEUTICS LTD	$3.16M	N/A	-337.50%	N/A	363.90%	0.51	N/A	N/A	N/A	N/A
NSRX	NASUS PHARMA LTD	N/A	N/A	N/A	46.79%	N/A	-1.22	0.12	N/A	N/A	N/A
STAA	STAAR SURGICAL CO	$1.28B	-25.20%	-19.60%	-25.78%	-33.10%	0.30	4.94	71.70%	-42.40%	-43.47%
NIVF	NEWGENIVF GROUP LTD	$209.71k	N/A	N/A	N/A	N/A	0.65	2.21	N/A	N/A	N/A
IBO	IMPACT BIOMEDICAL INC	$6.52M	-528.70%	-145.10%	907.95%	-2,020.30%	-2.56	0.06	-57.10%	-549,628.60%	-533,357.14%
ASRT	ASSERTIO HOLDINGS INC	$71.60M	-38.20%	-15.40%	-28.43%	-48.10%	1.93	1.59	67.90%	-37.00%	-34.30%
TXMD	THERAPEUTICSMD INC	$13.77M	-1.70%	-1.20%	-1.55%	-1.80%	0.41	2.89	100.00%	-17.90%	-20.44%
ADVB	ADVANCED BIOMED INC	$10.41M	-139.90%	-54.80%	-89.95%	398.80%	0.87	2.09	N/A	N/A	N/A
MTSR	METSERA INC	$6.62B	N/A	N/A	N/A	N/A	0.42	5.26	N/A	N/A	N/A
AKRO	AKERO THERAPEUTICS INC	$4.32B	-32.00%	-29.40%	-23.77%	-42.40%	0.07	16.80	N/A	N/A	N/A
BGM	BGM GROUP LTD	$68.36M	-2.40%	-2.10%	-3.78%	-20.90%	0.13	1.82	19.40%	-10.10%	-25.89%
LNSR	LENSAR INC	$145.04M	-777.70%	-86.20%	-123.60%	-176.80%	-3.67	1.81	47.90%	-99.20%	-99.16%
PMCB	PHARMACYTE BIOTECH INC	$6.32M	-12.50%	-11.20%	-2.55%	-3.80%	0.04	18.01	N/A	N/A	N/A
ELUT	ELUTIA INC	$38.54M	N/A	-54.60%	426.69%	-139.50%	-1.81	0.59	44.70%	-90.90%	-73.85%
AIM	AIM IMMUNOTECH INC	$5.69M	N/A	-198.50%	248.39%	683.60%	-1.63	0.10	71.10%	-13,360.30%	-12,858.68%
AHG	AKSO HEALTH GROUP	$893.12M	-80.00%	-75.60%	-82.42%	-557.00%	0.08	14.20	-1.90%	-913.40%	-1,121.81%
NDRA	ENDRA LIFE SCIENCES INC	$3.95M	-283.00%	-186.40%	-392.88%	-398.60%	0.91	3.21	N/A	N/A	N/A
IKT	INHIBIKASE THERAPEUTICS INC	$109.54M	-63.80%	-58.00%	-51.85%	-319.40%	0.11	10.09	N/A	N/A	N/A
IMCC	IM CANNABIS CORP	$5.82M	-22.50%	-2.70%	84.06%	49.40%	10.51	0.72	24.20%	-2.20%	9.50%
IRIX	IRIDEX CORP	$17.84M	-187.30%	-17.40%	-30.22%	-39.50%	4.21	1.96	39.50%	-11.00%	-10.86%
BRTX	BIORESTORATIVE THERAPIES INC	$12.29M	-145.30%	-93.90%	-221.32%	-192.50%	0.76	2.07	94.50%	-1,771.90%	-1,771.91%
IMDX	INSIGHT MOLECULAR DIAGNOSTICS INC	$172.00M	-2,898.10%	-117.30%	-144.31%	-1,076.10%	45.01	4.04	54.50%	-1,489.70%	-1,487.01%
POAI	PREDICTIVE ONCOLOGY INC	$6.48M	N/A	-179.60%	2,384.36%	-598.90%	-3.08	0.32	48.50%	-913.60%	-913.57%
KTTA	PASITHEA THERAPEUTICS CORP	$6.06M	-88.60%	-81.10%	-88.11%	4,718.40%	0.12	4.97	N/A	N/A	N/A
PRPH	PROPHASE LABS INC	$15.12M	-230.20%	-67.10%	-154.17%	-66.60%	2.68	0.96	60.40%	-1,241.10%	-757.69%
LYRA	LYRA THERAPEUTICS INC	$9.47M	-412.00%	-61.20%	-93.74%	-75.60%	31.41	2.78	100.00%	-5,043.60%	-5,041.17%
CNSP	CNS PHARMACEUTICALS INC	$4.42M	-183.90%	-139.40%	-117.66%	1,437.20%	0.11	10.22	N/A	N/A	N/A
ACON	ACLARION INC	$4.52M	-84.40%	-77.30%	-48.78%	2,399.00%	0.04	23.81	-26.40%	-11,215.90%	-10,996.43%
COCH	ENVOY MEDICAL INC	$17.32M	N/A	-273.70%	-1,026.26%	-101.80%	-1.33	0.94	-262.20%	-12,704.50%	-8,783.33%
CODX	CO-DIAGNOSTICS INC	$17.72M	-69.50%	-60.50%	-84.09%	-155.10%	0.13	4.13	39.60%	-3,586.00%	-3,582.18%
ADTX	ADITXT INC	$293.62k	-425.20%	-117.40%	-249.64%	-181.80%	1.60	0.02	-4,371.10%	-306,599.30%	-250,836.49%
EDSA	EDESA BIOTECH INC	$13.06M	-103.10%	-78.70%	-37.56%	570.50%	0.06	15.73	N/A	N/A	N/A
NRXS	NEURAXIS INC	$26.82M	-652.30%	-194.90%	-149.54%	689.90%	0.67	2.82	84.80%	-242.60%	-220.34%
ADAG	ADAGENE INC	$83.89M	-63.30%	-35.70%	-76.75%	184.60%	0.76	2.29	100.00%	-28,961.70%	-28,260.68%
ADIL	ADIAL PHARMACEUTICALS INC	$7.64M	-191.30%	-153.60%	-151.14%	-8,040.80%	0.22	5.02	N/A	N/A	N/A
MYNZ	MAINZ BIOMED NV	$6.06M	N/A	-207.80%	-508.89%	-2,883.90%	2.89	0.52	67.50%	-2,874.70%	-2,942.01%
MURA	MURAL ONCOLOGY PLC	$36.21M	-122.30%	-99.40%	-248.83%	-582.70%	0.49	2.87	N/A	N/A	N/A
EVGN	EVOGENE LTD	$10.98M	N/A	-38.50%	-53.84%	-87.80%	-14.85	1.89	13.90%	-385.20%	-272.59%
VIVS	VIVOSIM LABS INC	$7.02M	-33.00%	-21.40%	-20.06%	-143.80%	0.26	4.52	97.90%	-1,399.30%	-1,389.44%
EVO	EVOTEC SE	$1.45B	-16.90%	-8.10%	-8.51%	-8.40%	1.14	1.58	12.90%	-20.00%	-15.61%
MTVA	METAVIA INC	$24.03M	-212.00%	-107.20%	-191.84%	239.50%	0.92	2.08	N/A	N/A	N/A
MBIO	MUSTANG BIO INC	$6.35M	N/A	-107.30%	-284.92%	103.30%	3.13	1.34	N/A	N/A	N/A
MTNB	MATINAS BIOPHARMA HOLDINGS INC	$7.02M	-210.20%	-138.40%	-204.24%	-295.00%	0.49	4.07	N/A	N/A	N/A
ADGM	ADAGIO MEDICAL HOLDINGS INC	$17.53M	-222.60%	-112.40%	-203.07%	-361.10%	3.14	2.50	-841.30%	-24,320.80%	-23,396.28%
FONR	FONAR CORP	$100.30M	4.60%	3.70%	5.74%	6.50%	0.33	8.45	41.10%	7.50%	10.99%
MBRX	MOLECULIN BIOTECH INC	$14.08M	-1,676.40%	-128.10%	-194.08%	707.20%	-4.01	1.15	N/A	N/A	N/A
GDTC	CYTOMED THERAPEUTICS LTD	$25.39M	-42.40%	-38.10%	-47.70%	-75.20%	0.16	5.81	84.10%	-1,629.20%	-1,619.98%
GLMD	GALMED PHARMACEUTICALS LTD	$7.27M	-48.30%	-43.00%	-45.36%	-78.30%	0.12	8.71	N/A	N/A	N/A
MSPR	MSP RECOVERY INC	$309.52k	-1,748.80%	-28.40%	-10.59%	171.80%	-11.00	0.01	-3,573.50%	-4,375.60%	-885.55%
MRUS	MERUS NV	$7.17B	-55.30%	-46.20%	-45.90%	-98.30%	0.16	8.39	100.00%	-555.60%	-587.80%
HSCS	HEARTSCIENCES INC	$8.08M	-383.30%	-145.30%	-236.86%	-737.30%	1.05	1.47	57.80%	-140,296.50%	-129,710.70%
SMLR	SEMLER SCIENTIFIC INC	$391.73M	17.20%	12.90%	9.62%	15.40%	0.36	0.60	90.80%	86.20%	108.74%
FORA	FORIAN INC	$69.69M	-3.10%	-1.80%	-1.31%	-1.10%	0.57	2.66	59.30%	-3.60%	-1.62%
VANI	VIVANI MEDICAL INC	$95.38M	-194.70%	-68.60%	-115.09%	-76.80%	4.89	1.30	N/A	N/A	N/A
INAB	IN8BIO INC	$8.85M	-183.10%	-125.50%	-137.16%	-226.60%	0.27	7.03	N/A	N/A	N/A
CYCN	CYCLERION THERAPEUTICS INC	$6.24M	-22.60%	-20.70%	-22.71%	-36.00%	0.09	5.03	100.00%	-89.50%	-89.51%
INNV	INNOVAGE HOLDING CORP	$609.01M	-12.30%	-5.70%	-6.74%	-9.00%	1.12	1.07	18.00%	-3.60%	-2.86%
MOVE	MOVANO INC	$4.76M	-219.60%	-152.70%	-994.59%	-8,772.20%	2.46	1.35	-414.00%	-4,302.10%	-4,302.13%
MOLN	MOLECULAR PARTNERS AG	$135.88M	-50.30%	-44.80%	-54.02%	-95.80%	0.17	9.35	100.00%	-9,515.90%	-8,832.90%
RNTX	REIN THERAPEUTICS INC	$36.47M	-95.60%	-84.00%	-121.91%	1,321.10%	0.20	0.86	N/A	N/A	N/A
MNOV	MEDICINOVA INC	$81.42M	-23.10%	-21.80%	-25.03%	-318.90%	0.06	13.26	13.60%	-8,775.80%	-8,771.68%
MLEC	MOOLEC SCIENCE SA	$2.58M	-150.90%	-26.60%	-25.84%	-22.10%	10.22	1.48	-8.20%	-105.70%	-82.22%
PIII	P3 HEALTH PARTNERS INC	$63.54M	-192.00%	-18.60%	-48.64%	81.00%	14.49	0.31	-8.00%	-10.00%	-7.54%
SRXH	SRX HEALTH SOLUTIONS INC	$7.46M	N/A	-78.20%	41.92%	-386.40%	-1.74	0.33	34.80%	-43.30%	-45.29%
MHUA	MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO LTD	$7.43M	5.90%	5.00%	7.91%	8.70%	0.16	5.71	34.30%	10.40%	14.57%
RNA	AVIDITY BIOSCIENCES INC	$8.42B	-27.00%	-24.60%	-26.87%	-34.70%	0.10	16.91	100.00%	-4,136.00%	-4,136.00%
BYSI	BEYONDSPRING INC	$80.26M	N/A	-4.60%	-5.45%	-11.50%	-1.61	2.19	100.00%	119.00%	105.20%
CUE	CUE BIOPHARMA INC	$59.02M	-230.10%	-111.20%	-178.91%	-2,975.80%	1.24	1.60	100.00%	-469.30%	-463.15%
VTVT	VTV THERAPEUTICS INC	$69.48M	-206.40%	-55.90%	-92.45%	487.70%	8.71	4.98	100.00%	-115,029.40%	-115,029.41%
MLSS	MILESTONE SCIENTIFIC INC	$32.99M	-133.80%	-73.20%	-162.83%	-225.70%	1.41	2.03	72.80%	-76.80%	-76.78%
DYAI	DYADIC INTERNATIONAL INC	$40.89M	-355.30%	-60.70%	-113.79%	-79.20%	-16.36	2.02	59.90%	-134.80%	-123.19%
WORX	SCWORX CORP	$2.40M	-60.00%	-45.00%	-22.94%	111.40%	0.22	0.68	21.40%	-105.80%	-44.11%
CLSD	CLEARSIDE BIOMEDICAL INC	$21.30M	N/A	-124.10%	-219.76%	-47.60%	-1.32	3.87	70.50%	-2,061.90%	-2,008.71%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	624	+0.64%	+2.90%	+9.49%	-20.20%	-9.17x	4.99x	-99.14%	-9.57%	-19.67%	+59.31%	Strong Buy
Diagnostics & Research	56	+1.98%	-1.71%	+10.79%	+11.83%	22.03x	4.25x	-3.47%	+6.92%	+14.45%	+3.99%	Strong Buy
Drug Manufacturers - General	20	+0.87%	+1.10%	+5.98%	+2.01%	35.14x	6.26x	+64.80%	+11.73%	+19.54%	+8.05%	Buy
Drug Manufacturers - Specialty & Generic	77	+0.70%	-0.39%	-0.78%	-18.68%	-14.62x	2.21x	+10.48%	+4.13%	+9.69%	+35.70%	Strong Buy
Healthcare Plans	10	-0.97%	-8.09%	-4.64%	-26.28%	43.12x	2.05x	+12.53%	+3.88%	+9.46%	+21.30%	Buy
Health Information Services	55	+1.29%	-1.59%	+3.39%	-53.33%	64.86x	4.57x	-39.80%	-0.81%	+3.43%	+23.56%	Strong Buy
Medical Care Facilities	49	-1.87%	-1.42%	+0.29%	-25.38%	16.45x	5.25x	-80.81%	+7.16%	+16.38%	+16.85%	Buy
Medical Devices	139	-0.05%	-3.15%	-0.54%	-34.28%	27.18x	3.86x	+11.53%	+7.88%	+9.81%	+29.98%	Strong Buy
Medical Distribution	11	-1.21%	+2.91%	+6.98%	+50.46%	31.55x	556.06x	-11.84%	+3.12%	+19.04%	+5.23%	Buy
Medical Instruments & Supplies	56	+0.19%	-3.98%	+1.60%	-54.92%	37.95x	3.55x	+11.04%	+9.00%	+12.26%	+22.92%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Nov 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Amneal Pharmaceuticals (NASDAQ:AMRX)

Amneal Pharmaceuticals (NASDAQ:AMRX) is the #1 top healthcare stock out of 1097 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Amneal Pharmaceuticals (NASDAQ:AMRX) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: B.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a Due Diligence Score of 31, which is 6 points higher than the healthcare sector average of 25. It passed 10 out of 33 due diligence checks and has average fundamentals. Amneal Pharmaceuticals has seen its stock return 27.74% over the past year, overperforming other healthcare stocks by 51 percentage points.

Amneal Pharmaceuticals has an average 1 year price target of $13.50, an upside of 24.77% from Amneal Pharmaceuticals's current stock price of $10.82.

Amneal Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Amneal Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the #2 top healthcare stock out of 1097 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ironwood Pharmaceuticals (NASDAQ:IRWD) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: A.

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a Due Diligence Score of 3, which is -22 points lower than the healthcare sector average of 25. Although this number is below the industry average, our proven quant model rates IRWD as a "A".It passed 1 out of 33 due diligence checks and has weak fundamentals. Ironwood Pharmaceuticals has seen its stock lose -51.39% over the past year, underperforming other healthcare stocks by -28 percentage points.

3. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the #3 top healthcare stock out of 1097 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: B.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 35, which is 10 points higher than the healthcare sector average of 25. It passed 12 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock lose -5.26% over the past year, overperforming other healthcare stocks by 18 percentage points.

Embecta has an average 1 year price target of $18.50, an upside of 38.68% from Embecta's current stock price of $13.34.

Embecta stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Embecta, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 70 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 13.3%, which is 11 percentage points higher than the healthcare sector average of 2.18%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 36% indicates that its high dividend yield is sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 10.57%, which is 8 percentage points higher than the healthcare sector average of 2.18%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

3. Organon & Co (NYSE:OGN)

Organon & Co (NYSE:OGN) has an annual dividend yield of 8.89%, which is 7 percentage points higher than the healthcare sector average of 2.18%. Organon & Co's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Organon & Co's dividend has not shown consistent growth over the last 10 years.

Organon & Co's dividend payout ratio of 31.7% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.47% in the last day, and down -0.37% over the last week. Cabaletta Bio was the among the top gainers in the healthcare sector, gaining 46.15% yesterday.

Cabaletta Bio shares are trading higher after Cantor Fitzgerald maintained its overweight on the stock and raised Its price target from $15 to $30.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 54 points higher than the healthcare sector average of 17. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -11.08% in the past year. It has overperformed other stocks in the healthcare sector by 12 percentage points.

2. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bausch Health Companies has a valuation score of 57, which is 40 points higher than the healthcare sector average of 17. It passed 4 out of 7 valuation due diligence checks.

Bausch Health Companies's stock has dropped -23.7% in the past year. It has underperformed other stocks in the healthcare sector by -1 percentage points.

3. Auna Sa (NYSE:AUNA)

Auna Sa (NYSE:AUNA) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Auna Sa has a valuation score of 57, which is 40 points higher than the healthcare sector average of 17. It passed 4 out of 7 valuation due diligence checks.

Auna Sa's stock has dropped -12.57% in the past year. It has overperformed other stocks in the healthcare sector by 11 percentage points.

Are healthcare stocks a good buy now?

54.42% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 31.16% over the next year.

6.16% of healthcare stocks have a Zen Rating of A (Strong Buy), 11.85% of healthcare stocks are rated B (Buy), 47.27% are rated C (Hold), 25.09% are rated D (Sell), and 9.64% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 25.1x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Amneal Pharmaceuticals (NASDAQ:AMRX)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Embecta (NASDAQ:EMBC)

1. Select Medical Holdings (NYSE:SEM)

2. Dominari Holdings (NASDAQ:DOMH)

3. Organon & Co (NYSE:OGN)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Bausch Health Companies (NYSE:BHC)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Amneal Pharmaceuticals (NASDAQ:AMRX)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Embecta (NASDAQ:EMBC)

1. Select Medical Holdings (NYSE:SEM)

2. Dominari Holdings (NASDAQ:DOMH)

3. Organon & Co (NYSE:OGN)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Bausch Health Companies (NYSE:BHC)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.